Zheng JF - Search Results

1

Using JAK inhibitor to treat cytokine release syndrome developed after chimeric antigen receptor T cell therapy for patients with refractory acute lymphoblastic leukemia: A case report.

Zi FM, Ye LL, Zheng JF, Cheng J, Wang QM. Zi FM, et al. Among authors: zheng jf. Medicine (Baltimore). 2021 May 14;100(19):e25786. doi: 10.1097/MD.0000000000025786. Medicine (Baltimore). 2021. PMID: 34106613 Free PMC article.

2

I‑BET151 inhibits osteoclastogenesis via the RANKL signaling pathway in RAW264.7 macrophages.

Cheng J, Zheng J, Guo N, Zi F. Cheng J, et al. Mol Med Rep. 2017 Dec;16(6):8406-8412. doi: 10.3892/mmr.2017.7631. Epub 2017 Sep 26. Mol Med Rep. 2017. PMID: 28983590

3

lncRNA PVT1 promotes the angiogenesis of vascular endothelial cell by targeting miR‑26b to activate CTGF/ANGPT2.

Zheng J, Hu L, Cheng J, Xu J, Zhong Z, Yang Y, Yuan Z. Zheng J, et al. Int J Mol Med. 2018 Jul;42(1):489-496. doi: 10.3892/ijmm.2018.3595. Epub 2018 Mar 29. Int J Mol Med. 2018. PMID: 29620147

4

I-BET151 suppresses osteoclast formation and inflammatory cytokines secretion by targetting BRD4 in multiple myeloma.

Guo NH, Zheng JF, Zi FM, Cheng J. Guo NH, et al. Among authors: zheng jf. Biosci Rep. 2019 May 14;39(5):BSR20181245. doi: 10.1042/BSR20181245. Print 2019 May 31. Biosci Rep. 2019. PMID: 30455393 Free PMC article.

5

Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p.

Zheng JF, Guo NH, Zi FM, Cheng J. Zheng JF, et al. Mol Cell Biol. 2020 Jan 16;40(3):e00382-19. doi: 10.1128/MCB.00382-19. Print 2020 Jan 16. Mol Cell Biol. 2020. PMID: 31712391 Free PMC article.

6

LncRNA SNHG5 upregulation induced by YY1 contributes to angiogenesis via miR-26b/CTGF/VEGFA axis in acute myelogenous leukemia.

Li ZJ, Cheng J, Song Y, Li HH, Zheng JF. Li ZJ, et al. Among authors: zheng jf. Lab Invest. 2021 Mar;101(3):341-352. doi: 10.1038/s41374-020-00519-9. Epub 2020 Dec 14. Lab Invest. 2021. PMID: 33318617 Free article.

7

LncRNA PVT1 promotes the malignant progression of acute myeloid leukaemia via sponging miR-29 family to increase WAVE1 expression.

Cheng J, Song Y, Xu J, Li HH, Zheng JF. Cheng J, et al. Among authors: zheng jf. Pathology. 2021 Aug;53(5):613-622. doi: 10.1016/j.pathol.2020.11.003. Epub 2021 Feb 6. Pathology. 2021. PMID: 33558065

8

A transgene-encoded truncated human epidermal growth factor receptor for depletion of anti- B-cell maturation antigen CAR-T cells.

Wang Q, He F, He W, Huang Y, Zeng J, Zi F, Zheng J, Fei Y, Xu J, Song Y, Ye X, Lai R, Ye L, Zhu B. Wang Q, et al. Cell Immunol. 2021 May;363:104342. doi: 10.1016/j.cellimm.2021.104342. Epub 2021 Mar 14. Cell Immunol. 2021. PMID: 33765541 Free article.

9

Abnormal expression pattern of lncRNA H19 participates in multiple myeloma bone disease by unbalancing osteogenesis and osteolysis.

Guo N, Song Y, Zi F, Zheng J, Cheng J. Guo N, et al. Int Immunopharmacol. 2023 Jun;119:110058. doi: 10.1016/j.intimp.2023.110058. Epub 2023 Apr 13. Int Immunopharmacol. 2023. PMID: 37058751

10

lncRNA H19 plays a role in multiple myeloma via interacting with hnRNPA2B1 to stabilize BET proteins by targeting osteoclasts and osteoblasts.

Song Y, Guo N, Zi F, Zheng J, Cheng J. Song Y, et al. Int Immunopharmacol. 2024 Dec 5;142(Pt B):113080. doi: 10.1016/j.intimp.2024.113080. Epub 2024 Sep 16. Int Immunopharmacol. 2024. PMID: 39288624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters